ANTIHISTAMINES HELP ANESTHESIA

1 May 1994

Prophylaxis with antihistamines as part of general anesthetic management may help reduce clinical disturbances associated with anesthesia and surgery, according to a study conducted by Wilfried Lorenz, of the institute of theoretical surgery, Phillips University, Marburg, Germany.

Histamine is quite commonly released during anesthesia and surgery, and occasionally causes ill effects, such as erthymia, bronchospam and hypotension, according to Dr Lorenz. After induction of anesthesia and preoperative loading with either Ringer solution or Haemacell, the patients were randomized to receive antihistamine prophylaxis with dimethidine plus cimetidine, or placebo.

The authors report that clinically relevant or life-threatening disturbances occurred in 15 (including four life-threatening events) of 57 patients in the placebo/haemacell group and five of the 59 placebo-/Ringer group. In the antihistamine-treated groups combined, only one patient out of 115 experienced disturbance.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight